Crossmark

Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer’s Disease Comorbidity

Published Online: 2024-08-12

Authors

Fu, Mengjie

Wang, Qiuchen

Gao, Lihui

Ma, Qianhui

Wang, Ju
License Information

Text and Data Mining valid from 2024-08-12

Version of Record valid from 2024-08-12
More Information

Article History

Received: 22 February 2024

Accepted: 30 July 2024

First Online: 12 August 2024

Declarations

:

: The authors declare no competing interests.

Document is current